Single-cell RNA sequencing pinpointed macrophages as the primary cell type expressing THEMIS2 within the TME, suggesting that macrophages may be key players in THEMIS2-mediated immune regulation in GBM. The gene discussed is THEMIS2; the disease is glioblastoma.